Andere Sprachen Enveric Biosciences, Inc.

Aktien

A3DMHB

US29405E2081

ENVB

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
0,895 ^USD	-0,56 %		+1,64 %	-31,15 %

26.03.	Enveric Biosciences, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
19.03.	Sektor-Update: Aktien des Gesundheitswesens steigen am späten Nachmittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Enveric Biosciences : Shareholder Meeting - Form 8-K	28.03.
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023	26.03.
Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.03.
Sector Update: Health Care Stocks Rise Late Afternoon	19.03.
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	19.03.
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise	19.03.
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	19.03.
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease	19.03.
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease	19.03.
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets	12.03.
Enveric Biosciences Issues 228,690 Shares in Direct Offering	11.03.
Top Midday Gainers	29.02.
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts	29.02.
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session	29.02.
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds	29.02.
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB	28.02.
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property	26.02.
Sector Update: Health Care Stocks Rise in Late Afternoon	23.02.
Sector Update: Health Care Stocks Advance Friday Afternoon	23.02.
Enveric Biosciences Surging on Plans to Sell Cannabinoid IP Portfolio, Focus Shift to Psilocin Therapies	23.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Enveric Biosciences, Inc.

Aktien

A3DMHB

US29405E2081

ENVB

Andere Sprachen

Filter